Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,476 | 768 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $3,049 | 76 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,561 | 72 | $0 (2024) |
| Novo Nordisk Inc | $1,498 | 86 | $0 (2024) |
| ABBVIE INC. | $1,414 | 79 | $0 (2024) |
| Lilly USA, LLC | $1,097 | 68 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $946.47 | 48 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $873.68 | 37 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $762.81 | 49 | $0 (2024) |
| PFIZER INC. | $752.51 | 41 | $0 (2024) |
| Esperion Therapeutics, Inc. | $580.55 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,647 | 135 | AstraZeneca Pharmaceuticals LP ($536.83) |
| 2023 | $2,726 | 134 | ABBVIE INC. ($411.98) |
| 2022 | $3,595 | 155 | Biohaven Pharmaceutical Holding Company Ltd. ($525.69) |
| 2021 | $2,909 | 125 | Janssen Pharmaceuticals, Inc ($529.86) |
| 2020 | $1,558 | 73 | Novo Nordisk Inc ($288.15) |
| 2019 | $2,854 | 93 | Janssen Pharmaceuticals, Inc ($1,342) |
| 2018 | $914.80 | 40 | Janssen Pharmaceuticals, Inc ($281.76) |
| 2017 | $271.20 | 13 | Novo Nordisk Inc ($133.02) |
All Payment Transactions
768 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Gastroenterology | ||||||
| 12/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.43 | General |
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 389 | 544 | $133,526 | $47,699 |
| 2022 | 12 | 327 | 494 | $117,860 | $39,980 |
| 2021 | 8 | 246 | 383 | $80,148 | $27,568 |
| 2020 | 8 | 205 | 321 | $63,214 | $21,620 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 275 | $74,250 | $21,428 | 28.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $9,800 | $7,590 | 77.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 40 | $14,800 | $4,125 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $5,346 | $3,243 | 60.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $9,200 | $2,525 | 27.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $4,250 | $2,458 | 57.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 47 | $8,930 | $2,406 | 26.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $2,990 | $1,569 | 52.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 17 | 18 | $1,960 | $924.92 | 47.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,080 | $773.01 | 71.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $920.00 | $658.49 | 71.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 282 | $76,140 | $22,012 | 28.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $4,900 | $3,901 | 79.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 25 | $9,250 | $3,146 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 20 | 20 | $3,960 | $2,330 | 58.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $9,200 | $2,168 | 23.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,750 | $1,719 | 62.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 26 | $4,940 | $1,515 | 30.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 23 | 23 | $2,750 | $1,505 | 54.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $1,080 | $736.85 | 68.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 13 | 15 | $2,100 | $455.73 | 21.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $640.00 | $438.00 | 68.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 15 | $150.00 | $51.83 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 244 | $60,590 | $18,996 | 31.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $2,172 | $1,757 | 80.9% |
About Dr. Alyssa Pagliere Osan, M.D
Dr. Alyssa Pagliere Osan, M.D is a Family Medicine healthcare provider based in Valparaiso, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1760801658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alyssa Pagliere Osan, M.D has received a total of $17,476 in payments from pharmaceutical and medical device companies, with $2,647 received in 2024. These payments were reported across 768 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($17,476).
As a Medicare-enrolled provider, Pagliere Osan has provided services to 1,167 Medicare beneficiaries, totaling 1,742 services with total Medicare billing of $136,866. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Valparaiso, IN
- Active Since 04/08/2014
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760801658
Products in Payments
- XARELTO (Drug) $2,590
- NURTEC ODT (Drug) $1,106
- VRAYLAR (Drug) $807.93
- Ozempic (Drug) $720.57
- XIFAXAN (Drug) $633.12
- JARDIANCE (Drug) $597.05
- BREZTRI (Drug) $576.03
- NEXLIZET (Drug) $547.33
- TRINTELLIX (Drug) $507.15
- FARXIGA (Drug) $484.90
- UBRELVY (Drug) $482.60
- Omnipod (Device) $464.85
- INVOKANA (Drug) $458.58
- AIRSUPRA (Drug) $397.60
- QULIPTA (Drug) $342.48
- MOUNJARO (Drug) $280.10
- TRULICITY (Drug) $273.42
- Tresiba (Drug) $260.82
- Rybelsus (Drug) $258.37
- SOLIQUA 100/33 (Biological) $228.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Valparaiso
Kenneth Blumenthal, Do, DO
Family Medicine — Payments: $29,294
Dr. Christopher Osan, M.d, M.D
Family Medicine — Payments: $18,908
Dr. Arjun Gupta, Md, MD
Family Medicine — Payments: $3,030
Janet Bilder, Do, DO
Family Medicine — Payments: $2,989
Chike Okolocha, Do, DO
Family Medicine — Payments: $2,849
Ather Malik, Do, DO
Family Medicine — Payments: $2,598